Cohort Study of Long-term Safety of Upadacitinib for the Treatment of Ulcerative Colitis and Crohn’s Disease in a Real-world Setting in Europe

First published 15/12/2023

Last updated 08/08/2024

EU PAS number:

EUPAS107124

Study

Ongoing

Documents

Study protocol

Initial protocol

p24343-protocol-pmos-v1.0_Redacted 2.pdf

English (13.04 MB - PDF)View document

Study results

Study report

Other information

ENCePP Seal

This study has been awarded the ENCePP seal

ENCePP Seal documents

Conflicts of interest of investigators

DeclarationofInterests-Annex5-JReutfors

English (105.48 KB - PDF)View document

Composition of steering group and observers

EUPAS107124-107878

English (60.64 KB - PDF)View document

Signed code of conduct

ENCePP Declaration of compliance_signed.pdf

English (38.09 KB - PDF)View document

Signed code of conduct checklist

ENCePP Checklist Code of conduct_signed.pdf

English (470.09 KB - PDF)View document

Signed checklist for study protocols

Signed ENCePP checklist for Upa IBD PASS v1.0 Study Protocol.pdf

English (1.11 MB - PDF)View document

Secondary tabs